What are private transactions in AVALON PHARMA?

Private transactions are negotiated off-exchange between buyer and seller. They don't affect the day's closing price, and counterparty identities are not disclosed.

What do major-shareholder changes mean?

Major shareholder changes are disclosed when a holder crosses the 5%, 10%, 20%, 25%, 30%, or 50% thresholds. An increase often signals strategic conviction; a decrease can reflect portfolio rebalancing.

Where do AVALON PHARMA announcements come from?

Tadawul disclosures are issued after CMA review and must be published as soon as a material event affecting investors occurs.

AVALON PHARMA (4016) — Announcements, Private Transactions & Major Shareholder Changes

Total 7 events · Pharma, Biotech & Life Science

AVALON PHARMA (4016) stock page — follow the latest official Tadawul announcements and news for AVALON PHARMA, private transactions, and major-shareholder changes. Full legal name: Middle East Pharmaceutical Industries Co.

AVALON PHARMA announcements & news on Tadawul

📰 إعلان 4016 TASI 2026-10-07 05:04

AVALON PHARMA

Middle East Pharmaceutical Industries Co. announces signing of a Memorandum of Understanding with Aurisco Pharma for Strategic Cooperation on Oligonucleotide and Other Complex Pharmaceutical Products

📰 إعلان 4016 TASI 2026-09-17 12:43

AVALON PHARMA

Middle East Pharmaceutical Industries Co. Announces the renewal of a Shariah-compliant Bank facility agreement with Banque Saudi Fransi.

💼 صفقة خاصة 4016 TASI 2026-09-16 09:13

Private transaction in AVALON PHARMA

worth 4.73M SAR · at 64.95 SAR

📰 إعلان 4016 TASI 2026-08-20 05:00

AVALON PHARMA

Middle East Pharmaceutical Industries Co announces the renewal of a Shariah-compliant credit facility agreement with Alinma Bank.

📰 إعلان 4016 TASI 2026-08-18 05:01

AVALON PHARMA

Middle East Pharmaceutical Industries Co. Announces Contract Sign Off with Bio-Thera Solutions Inc. A global biopharmaceutical company specializing in innovative biologics and biosimilars

📰 إعلان 4016 TASI 2026-08-10 05:43

AVALON PHARMA

Middle East Pharmaceutical Industries Co. announces the board of director’s decision to distribute cash dividends for the first half of 2026.

📰 إعلان 4016 TASI 2026-08-06 05:03

AVALON PHARMA

Middle East Pharmaceutical Industries Co. announces its Interim Financial results for the Period Ending on 2026-06-30 (Six Months)